Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide7 min read

Sprout Cost 2026: From $99/Month - The Math Explained

Sprout's GLP-1 pricing: semaglutide from $99/month and tirzepatide from $149 on the 12-month plan ($149/$199 monthly); brand Wegovy $1,799. The full math.

Updated September 24, 2026

Medically reviewed on

How we review

Key takeaways

  • Sprout's compounded semaglutide costs $99/month on the 12-month plan ($1,188 billed upfront), $110 on the 6-month plan, $125 on the 3-month plan or $149 month to month; tirzepatide is $149, $160, $180 or $199 on the same plans; brand-name Wegovy is from $1,799/month.
  • First-year math: $1,188 for semaglutide and $1,788 for tirzepatide on the 12-month plan, billed upfront, or $1,588 and $2,188 month to month with the first-month discount; $21,388+ for Wegovy - which altRx lists $220/month cheaper at $1,579.
  • On semaglutide, Sprout's 12-month $99 prices tied-fourth of nine with Medvi's $99 promo - welludr $41, embody $49 and altRx $89 undercut it; month to month, its $149 ties TrimRx.
  • The premium buys 2-day fulfillment, the option to move to brand-name Wegovy without switching providers, and fast named-human support - if none of those matter, the value tier wins.

Four plan lengths, one discount

The short answerSprout costs from $99/month for compounded semaglutide and from $149/month for compounded tirzepatide on its 12-month plan (billed upfront: $1,188 and $1,788), $110 and $160 on the 6-month plan, $125 and $180 on the 3-month plan, or $149 and $199 month to month with no commitment - the same price at any dose, with no membership fee. Brand-name Wegovy is from $1,799/month. Prescriptions ship within 2 days of approval.

Treatment starts fast, but the number to budget against is the ongoing rate - so here's the year, priced honestly.

The 12-month math

GLP-1 treatment is measured in months, so annual cost is the honest unit:

Plan12-month plan (billed upfront)Month to monthFirst year month to month
Compounded semaglutide$99/mo ($1,188)$149$1,788
Compounded tirzepatide$149/mo ($1,788)$199$2,388
Brand-name Wegovy-from $1,799$21,588+

The 12-month plan is the cheapest year if you're sure of it; plans renew until cancelled, and you can cancel any time before the next refill.

The Wegovy row isn't a typo - that's what a year of brand-name medication costs cash-pay, and it's why the compounded lane exists. If brand-name matters to you, note that altRx lists Wegovy at $1,579/month - $220/month less - alongside Ozempic and Zepbound.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

How does Sprout's price compare to other providers?

Against every provider's real listed semaglutide price: welludr $41 (12-month plan), embody $49 flat, altRx $89, then Sprout's 12-month $99 tied with Medvi's $99 promo, HealthRx $125 after a $39 first month, TrimRx $149, SHED at $199 with coaching, and DirectMeds $249 for sublingual semaglutide. On its 12-month plan Sprout prices tied-fourth of nine on the same molecule; month to month, its $149 ties TrimRx.

So what does the premium over the value tier buy? Two concrete things and one soft one: fulfillment within 2 days (only embody, DirectMeds and HealthRx match or beat that), the option to move to brand-name Wegovy without switching providers, and the personalized-plan onboarding its reviews praise. If none of those move you, the cheapest-GLP-1 index is the better shopping list.

Worth it, or walk?

Worth it: switchers timing a transition who can't absorb a shipping gap, anyone who wants the Wegovy door left open, and people who value fast, named-human support - "shout out to Frank" appears in more than one review for a reason.

Walk: if price per milligram is the whole decision. The same compounded semaglutide runs $41-$99 across the value tier, and over a year that difference funds a vacation.

→ The extreme version of that choice: Sprout vs welludr's $41, compared

This article is general information, not medical advice. Prices as listed at the time of writing - confirm current terms on Sprout's site.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)